Walleye Capital
North America, Minnesota, United States, Plymouth
Description
Walleye Capital provides tailored investment strategies, hedge funds, risk management, and wealth management advisory services.
Investor Profile
Walleye Capital has backed more than 14 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Belgium, Israel.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (29%)
- Series C (21%)
- Post Ipo Equity (14%)
- Series D (14%)
- Series G (7%)
- Series E (7%)
- Series F (7%)
Country Focus
- United States (79%)
- Belgium (14%)
- Israel (7%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- E-commerce
- Saas
- Oncology
- Artificial Intelligence (Ai)
- Food And Beverage
- Internet
- Payments
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
